Zevra Therapeutics Inc. (ZVRA) — Capital Reinvestment Ratio
Zevra Therapeutics Inc. (ZVRA) has a Capital Reinvestment Ratio of 0.12x as of September 2025, meaning it reinvests 0% of its operating cash flow ($4.71 Million) in capital expenditures ($554.00K). See ZVRA net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zevra Therapeutics Inc. Capital Reinvestment Ratio (2021–2021)
This chart tracks Zevra Therapeutics Inc.'s Capital Reinvestment Ratio across 1 annual periods. Check total reinvestment intensity of Zevra Therapeutics Inc. to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zevra Therapeutics Inc. (2021–2021)
Year-by-year Capital Reinvestment Ratio for Zevra Therapeutics Inc. from 2021 to 2021. For live market cap and broader valuation context, see market value of Zevra Therapeutics Inc..
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.01x | $10.44 Million | $102.00K | — |